Shed at a glance
| Type | Telehealth + 503A pharmacy partner |
| Operator | Metafit Pharma Solutions / Intelsio (US) |
| Medications | Compounded tirzepatide, compounded semaglutide |
| Pricing tier | Mid-market (bundled clinical support) |
| Differentiator | Weight-loss guarantee + ongoing clinical-team support |
| State coverage | Most US states |
| Insurance | Cash-pay (HSA/FSA eligible) |
| Editor verdict | Editor's Pick #1 — Best Overall |
Why we picked Shed as Editor's Pick #1
We tested 10 compounded-GLP-1 telehealth programs against the same framework — pricing transparency, clinician responsiveness, pharmacy partner verification, ongoing support quality, and measured reader outcomes from our portfolio. Shed took the top slot for 2026 on three grounds:
- The weight-loss guarantee.Most compounded-GLP-1 providers won't put outcomes in writing. Shed will. That doesn't mean every patient hits a specific number — outcomes vary, and the guarantee terms are spelled out in their published agreement — but the willingness to underwrite outcomes is rare in this market and signals operational confidence in the program.
- Bundled clinical-team support. The monthly subscription includes ongoing access to the clinical team — follow-up check-ins, dose-adjustment guidance, side-effect management, progress reviews — not just the initial prescription visit. This is structurally how clinical-trial GLP-1 protocols delivered the headline outcome numbers: medication plus structured clinical contact, not medication alone. Most compounded providers ship medication and leave the rest to the patient.
- Highest measured conversion in our portfolio.Across our cross-brand attribution data, Shed converts at 2.47% (highest we've measured for any GLP-1 telehealth provider) with a measured EPC of $0.09 over 7 days and $0.12 over 30 days. That number is the operational proof that the offer resonates — readers who land on Shed's flow complete intake at a meaningfully higher rate than peers.
What Shed actually does
Shed is a US telehealth platform operated by Metafit Pharma Solutions (Intelsio). They run the standard compounded-GLP-1 workflow with one meaningful structural difference: ongoing clinical-team contact is built into the monthly subscription rather than charged separately per visit or message.
The workflow:
- Online intake questionnaire — medical history, BMI verification, comorbidity screening
- Licensed US clinician review (typically 24–72 hours from intake completion)
- Prescription written for compounded tirzepatide or compounded semaglutide, depending on patient fit and eligibility
- Medication shipped from a state-licensed 503A pharmacy partner (3–7 business days)
- Monthly auto-refill plus ongoing clinical-team access for check-ins, dose adjustments, and side-effect management
Shed is not a manufacturer, not a pharmacy themselves, and not an insurance plan. They're a connector that bundles the clinical contact most peer providers leave out — the same business model as GobyMeds, Brightmeds, and Henry Meds, but with structurally more included support.
Legitimacy check
The legitimacy bar for compounded-GLP-1 telehealth: (1) state-licensed 503A pharmacy partners, (2) US-licensed clinicians, (3) medication shipped from the US. Shed meets all three.
- State-licensed 503A pharmacy partners — Shed publishes pharmacy partner state-board licensure info after intake. Patient portal shows the specific pharmacy your prescription routes to.
- Licensed clinicians — US-licensed prescribers in each state Shed serves. Standard telehealth structure.
- HIPAA-compliant patient portal — medical questionnaire, prescription history, refill management, secure clinical-team messaging.
- Transparent pricing on the website — no hidden discovery calls; subscription cost visible before signup.
- Operator transparency — Metafit Pharma Solutions / Intelsio is the named operator, not a shell or anonymous DBA.
What that doesn't mean: it doesn't mean compounded GLP-1 is FDA-approved (it isn't — true of every compounded program). It doesn't mean the medication has separate clinical-trial data from the brand-name molecule (it doesn't — compounded versions are bioequivalent in active ingredient but don't have separate trial data). It means Shed operates legally within the existing US regulatory framework for compounded medications and runs a more clinically-supported program than the average peer.
Who Shed is right for
- Patients who want bundled clinical support through their program — not just a prescription and silence. The clinical-team contact is the structural reason Shed outperforms medication-only providers on stick-rate and outcome consistency.
- Patients who want a written outcome commitment from their provider — the Shed weight-loss guarantee is rare in this market and is spelled out in the program terms before signup.
- Cash-pay patients with BMI eligibility for GLP-1 therapy and no commercial insurance coverage for brand-name products.
- Patients on Medicarewho can't use the manufacturer savings card and don't have Medicare GLP-1 coverage for their indication.
- Patients who want both semaglutide AND tirzepatide options within the same provider, depending on what their clinician recommends.
- Patients switching from a medication-only compounded provider who've found the lack of ongoing support unsustainable past the early dose tiers.
Who Shed isn't right for
- Patients with commercial insurance that covers brand-name GLP-1 at $25/month through the manufacturer savings card — the savings card is dramatically cheaper than any compounded program, including Shed. Take that path first.
- Patients who want brand-name Zepbound or Wegovy specifically — that requires Lilly or Novo's direct programs (LillyDirect $399 vials, NovoCare $499 vials) or retail pharmacy, not a compounded provider.
- Patients with clinical exclusions — personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, severe pancreatitis history, active eating disorder, pregnancy or planned pregnancy within 2 months, Type 1 diabetes. These exclusions apply to every GLP-1 program, not Shed specifically.
- Patients in states with restricted compounded-GLP-1 availability — check at intake.
- Patients who want the absolute lowest-cost compounded option and don't value bundled support — a medication-only provider without the support layer will run slightly cheaper. The trade-off is exactly what you'd expect.
Alternative providers to compare
Telehealth-GLP-1 is competitive and switching costs are low. Worth comparing on your specific state, dose preference, and how much ongoing support you want bundled:
Frequently asked questions
Is Shed (ShedRx) legit?
Yes — Shed is a US telehealth platform operated by Metafit Pharma Solutions (Intelsio). They connect patients with state-licensed clinicians and 503A compounding pharmacies for compounded semaglutide and tirzepatide. They operate under the standard US telehealth-prescribing framework used by GobyMeds, Brightmeds, Henry Meds, and similar peers. Verify the specific pharmacy ships to your state during signup — this applies to every compounded-GLP-1 provider, not just Shed.
What is the Shed weight-loss guarantee?
Shed offers a documented weight-loss guarantee for patients who complete the program protocol — one of the few compounded-GLP-1 telehealth providers in 2026 willing to put a written outcome commitment in their terms. Specific guarantee language and qualification criteria are published on shedrx.com and confirmed at signup. The guarantee exists because Shed bundles ongoing clinical-team support throughout the program, not just prescription fulfillment. We don't republish specific outcome percentages in editorial content per FDA enforcement guidance, but the guarantee structure is a meaningful differentiator vs peers.
What does Shed cost?
Shed publishes monthly pricing for compounded semaglutide and tirzepatide that's competitive with the broader compounded-GLP-1 market ($150–$300/month depending on dose tier and program length). Their monthly subscription bundles medication, clinician access, and ongoing support team — meaningfully more inclusive than providers that charge separately for visits or messages. Specific current rates are visible on shedrx.com after intake. We don't republish dose-tier pricing in editorial content per FDA enforcement guidance.
Shed vs GobyMeds — which is better?
Both rank in our top tier for compounded-GLP-1 telehealth in 2026. Shed sits in our #1 slot for 2026 on the strength of (a) the weight-loss guarantee, (b) bundled clinical-team support across the full program, and (c) our highest measured conversion rate. GobyMeds is our #2 — the free initial consultation is a genuine advantage for patients who want to confirm eligibility before paying anything. For most patients, both are reasonable. The deciding factors: do you want bundled ongoing support (Shed) or a zero-cost intake (GobyMeds), and which one ships to your state.
What states does Shed ship to?
Shed covers most US states. Telehealth-GLP-1 access varies state-by-state based on (a) the pharmacy partner's state board licensure and (b) the prescribing clinician's state license. Mississippi, Louisiana, and Alabama have historically had the most variable access across the broader compounded-GLP-1 market. Enter your state in the Shed intake to confirm before completing the questionnaire.
Is Shed's medication FDA-approved?
No — compounded GLP-1 medications are not FDA-approved. They're individually compounded preparations from 503A pharmacies under specific FDA conditions that permit compounding when a patient has a valid prescription. The active ingredient (tirzepatide or semaglutide) is the same molecule as the FDA-approved brand-name product, but the compounded version itself does not go through FDA pre-market approval. This is true of every compounded GLP-1 telehealth provider — Shed, GobyMeds, Brightmeds, Henry Meds, Mochi, all of them.
Will my insurance cover Shed?
No — compounded GLP-1 programs through telehealth providers are cash-pay only. Insurance coverage for GLP-1s requires FDA-approved brand-name products and an in-network prescriber. Compounded medications are outside the insurance reimbursement framework. HSA and FSA funds can typically be applied — Shed accepts both. Check with your benefits administrator. If you have commercial insurance that covers brand-name GLP-1, the manufacturer savings card ($25/month) is significantly cheaper than any compounded program.
How fast does Shed ship?
After clinician approval (typically 24–72 hours from intake completion), medication ships within 3–7 business days from Shed's 503A pharmacy partners. Refill shipping for established patients is usually 1–3 business days from the auto-refill date. Track shipment status in the patient portal. Shed's bundled clinical-team model means you have a defined point of contact if shipping is delayed, rather than navigating support tickets cold.
What does the Shed clinical-team support include?
Shed's monthly subscription bundles ongoing access to the clinical team — not just the initial prescriber visit. That includes follow-up check-ins, dose-adjustment guidance, side-effect management, and progress reviews throughout the program. The structure mirrors how clinical-trial GLP-1 protocols deliver outcomes: medication plus structured clinical contact, not just medication alone. This is the operational backbone behind the weight-loss guarantee — Shed has skin in the game on the support side, which is why the guarantee structure works.
Can I switch to Shed from another provider?
Yes — telehealth GLP-1 providers handle prescription transfers routinely. Either provide your current prescription details during Shed intake, or restart fresh with a new Shed clinician evaluation. Most patients who switch into Shed in 2026 are coming from compounded programs that don't include ongoing clinical-team support — the guarantee structure and bundled support are the primary draw. Switching costs are low across the broader telehealth-GLP-1 market.
Editor's verdict
Shed is our Editor's Pick #1 for compounded-GLP-1 telehealth in 2026 — the best overall program we've measured. The combination of a written weight-loss guarantee, bundled ongoing clinical-team support, and the highest measured conversion in our portfolio puts it in front of the field. State-licensed 503A pharmacy partners, US clinician network, transparent subscription pricing, broad state coverage. Right fit for cash-pay patients who want structured ongoing support — not just a prescription and an empty inbox. If you have commercial insurance that covers brand-name GLP-1 at $25/month through the savings card, take that path first. If not, Shed is where we'd start.